Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
5.4
-51.21%
40%
—
127.01%
Every year
—
5 Years
Score5.4
Net Growth-51.21%
Net Trend40%
Net Income Consistency—
Rev Growth127.01%
Rev TrendEvery year
Revenue Consistency—
Corcept Therapeutics Incorporated fundamental performance
Between 2020 and 2025, revenue grew from $ 353M to $ 761M and net income declined from $ 106M to $ 99M. Revenue increased in every one of those 5 years; net income in 2.
Between 2015 and 2025, revenue grew from $ 50M to $ 761M and net income went from -$ 6M to $ 99M. Revenue increased in every one of those 10 years; net income in 6.
Corcept Therapeutics Incorporated currently holds a 20-year HDB Score of 5.4 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 112.18 | — |
1 Year2025-08-12 | $ 73.59 | 52.44% |
5 Years2021-08-12 | $ 20.54 | 446.15% |
10 Years2016-08-12 | $ 5.77 | 19x |
20 Years2006-08-11 | $ 3.69 | 30x |
All Time2004-04-14 | $ 12.23 | 9x |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | All Time2004-04-14 |
|---|---|---|---|---|---|---|
| Price | $ 112.18 | $ 73.59 | $ 20.54 | $ 5.77 | $ 3.69 | $ 12.23 |
| Return | — | 52.44% | 446.15% | 19x | 30x | 9x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 830M | $ 54M | $ 308M |
| 2025 | $ 761M | $ 99M | $ 372M |
| 2024 | $ 675M | $ 139M | $ 383M |
| 2023 | $ 482M | $ 106M | $ 368M |
| 2022 | $ 401M | $ 101M | $ 431M |
| 2021 | $ 365M | $ 112M | $ 223M |
| 2020 | $ 353M | $ 106M | $ 476M |
| 2019 | $ 306M | $ 94M | $ 275M |
| 2018 | $ 251M | $ 75M | $ 206M |
| 2017 | $ 159M | $ 129M | $ 104M |
| 2016 | $ 81M | $ 8M | $ 51M |
| 2015 | $ 50M | -$ 6M | $ 40M |
| 2014 | $ 26M | -$ 31M | $ 24M |
| 2013 | $ 10M | -$ 46M | $ 54M |
| 2012 | $ 3M | -$ 38M | $ 93M |
| 2011 | $ 0.00 | -$ 32M | $ 39M |
| 2010 | -$ 25M | $ 24M | |
| 2009 | $ 29K | -$ 20M | $ 23M |
| 2008 | $ 209K | -$ 20M | $ 18M |
| 2007 | $ 482K | -$ 11M | $ 17M |
| 2006 | $ 294K | -$ 24M | $ 9M |
| 2005 | -$ 20M | $ 29M | |
| IPO2004 | -$ 15M | $ 37M |
Explore beyond CORT
You're looking at Corcept Therapeutics Incorporated. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
